Live Breaking News & Updates on Intas Pharmaceutical

Stay updated with breaking news from Intas pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

US FDA hits Intas Pharma with warning letter; notes data integrity lapses at Ahmedabad plant

The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits ....

United States , Intas Pharma , Drug Administration , Chudgar Group , Intas Pharmaceuticals , United States Food , Intas Pharmaceutical , Pharmaceuticals Limited , Import Alert , Ahmedabad Based Chudgar , S Fda ,

Moneycontrol Selects: Top stories this morning

Our specially curated package of the most interesting articles to help you stay at the top of your game. ....

Tamil Nadu , United States , Peter Lynch , Intas Pharma , Chennai International Airport , Drug Administration , Honasa Consumer , United States Food , Intas Pharmaceutical , Moneycontrol Selects , India Services , Cyclone Michaung , Byju Raveendran ,

EMA Accepts MAA for Dong-A ST's Ustekinumab Biosimilar | Goodwin

On July 14, Dong-A ST announced that the European Medicines Agency accepted its Marketing Authorization Application (MAA) for DMB-3115, a biosimilar referencing STELARA (ustekinumab).. ....

United Kingdom , Seika Pharma , Intas Pharmaceuticals , European Medicines Agency , Marketing Authorization Application , Meiji Seika Pharma , Intas Pharmaceutical , Accord Healthcare ,

Life-threatening cancer drug shortages are result of a cascade of troubles

Life-threatening cancer drug shortages are result of a cascade of troubles
umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.

United States , South Africa , Fresenius Kabi , Stephen Schondelmeyer , American Cancer Society , National Comprehensive Cancer Network Best Practices Committee , Intas Pharmaceutical ,

Accord Healthcare and Intas Pharmaceuticals Sued For Infringement Over Rydapt Cancer Drug

Plaintiffs Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc. (Dana Farber) filed a complaint against defendants Accord ....

United States , North Carolina , Dana Farber , Dana Farber Cancer Institute Inc , Drug Administration , Delaware Corporation , Accord Healthcare Inc , Plaintiffs Novartis Pharmaceuticals Corporation , Dunn Crutcher , Intas Pharmaceutical , Dana Farber Cancer Institute , Middle District , Tyrosine Kinase Activity ,